Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over
Objective: The main detrimental factor in female fertility is maternal age. Clinical pregnancy and live birth rates decline gradually with age and this decline is dramatical over 40 years. In this study, we examined the in vitro fertilization/intracytoplasmic sperm injection cycle outcomes of women...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Network
2022-03-01
|
| Series: | Gynecology Obstetrics & Reproductive Medicine |
| Subjects: | |
| Online Access: | https://gorm.com.tr/index.php/GORM/article/view/1220 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823857379823845376 |
|---|---|
| author | Oya Aldemir Runa Ozelci Serdar Dilbaz Berna Dilbaz Emre Baser Yaprak Ustun |
| author_facet | Oya Aldemir Runa Ozelci Serdar Dilbaz Berna Dilbaz Emre Baser Yaprak Ustun |
| author_sort | Oya Aldemir |
| collection | DOAJ |
| description |
Objective: The main detrimental factor in female fertility is maternal age. Clinical pregnancy and live birth rates decline gradually with age and this decline is dramatical over 40 years. In this study, we examined the in vitro fertilization/intracytoplasmic sperm injection cycle outcomes of women aged 40 years and over.
Study Design: This retrospective cohort study included 336 fresh in vitro fertilization/ICSI cycles of women aged ≥40 years. Six groups, stratified by one-year intervals were composed according to age: 40 years; 41 years; 42 years; 43 years; 44 years, and ≥45 years. The primary outcomes were the clinical pregnancy and live birth rates.
Results: The clinical pregnancy rate was 18.6% in 40 years old women and it decreased to 4% in women aged ≥45 years. The live birth rates in women aged 40 and 41 years (10% and 6.1% respectively) were higher than the live birth rates in women aged 42 and 43 years (4.3% and 3.8% respectively). There was no live birth in women aged 44 and over. The miscarriage rate was 46.2% at age 40 and it increased to 100% at age 44 and over.
Conclusion: The clinical pregnancy and the live birth rates decreased significantly with every single year after 40 years of age. In patients between the ages of 40-43, the live birth rate is acceptable but starting an in vitro fertilization cycle beyond 43 years of age does not seem to be reasonable.
|
| format | Article |
| id | doaj-art-cc12982555244eac8330f7b8a0da4f1c |
| institution | Kabale University |
| issn | 1300-4751 2602-4918 |
| language | English |
| publishDate | 2022-03-01 |
| publisher | Medical Network |
| record_format | Article |
| series | Gynecology Obstetrics & Reproductive Medicine |
| spelling | doaj-art-cc12982555244eac8330f7b8a0da4f1c2025-02-11T21:14:40ZengMedical NetworkGynecology Obstetrics & Reproductive Medicine1300-47512602-49182022-03-0128110.21613/GORM.2022.1220Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and OverOya Aldemir0Runa Ozelci1Serdar Dilbaz2Berna Dilbaz3Emre Baser4Yaprak Ustun5Ankara Etlik Zübeyde Hanım Kadın Hastalıkları Eğitim ve Araştırma HastanesiAnkara Etlik Zübeyde Hanım Kadın Hastalıkları Eğitim ve Araştırma HastanesiAnkara Etlik Zübeyde Hanım Kadın Hastalıkları Eğitim ve Araştırma HastanesiAnkara Etlik Zübeyde Hanım Kadın Hastalıkları Eğitim ve Araştırma HastanesiBozok Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve DoğumAnkara Etlik Zübeyde Hanım Kadın Hastalıkları Eğitim ve Araştırma Hastanesi Objective: The main detrimental factor in female fertility is maternal age. Clinical pregnancy and live birth rates decline gradually with age and this decline is dramatical over 40 years. In this study, we examined the in vitro fertilization/intracytoplasmic sperm injection cycle outcomes of women aged 40 years and over. Study Design: This retrospective cohort study included 336 fresh in vitro fertilization/ICSI cycles of women aged ≥40 years. Six groups, stratified by one-year intervals were composed according to age: 40 years; 41 years; 42 years; 43 years; 44 years, and ≥45 years. The primary outcomes were the clinical pregnancy and live birth rates. Results: The clinical pregnancy rate was 18.6% in 40 years old women and it decreased to 4% in women aged ≥45 years. The live birth rates in women aged 40 and 41 years (10% and 6.1% respectively) were higher than the live birth rates in women aged 42 and 43 years (4.3% and 3.8% respectively). There was no live birth in women aged 44 and over. The miscarriage rate was 46.2% at age 40 and it increased to 100% at age 44 and over. Conclusion: The clinical pregnancy and the live birth rates decreased significantly with every single year after 40 years of age. In patients between the ages of 40-43, the live birth rate is acceptable but starting an in vitro fertilization cycle beyond 43 years of age does not seem to be reasonable. https://gorm.com.tr/index.php/GORM/article/view/1220Advanced maternal ageClinical pregnancyIn vitro fertilizationLive birth |
| spellingShingle | Oya Aldemir Runa Ozelci Serdar Dilbaz Berna Dilbaz Emre Baser Yaprak Ustun Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over Gynecology Obstetrics & Reproductive Medicine Advanced maternal age Clinical pregnancy In vitro fertilization Live birth |
| title | Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over |
| title_full | Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over |
| title_fullStr | Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over |
| title_full_unstemmed | Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over |
| title_short | Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over |
| title_sort | intracytoplasmic sperm injection cycle outcomes in women aged 40 years and over |
| topic | Advanced maternal age Clinical pregnancy In vitro fertilization Live birth |
| url | https://gorm.com.tr/index.php/GORM/article/view/1220 |
| work_keys_str_mv | AT oyaaldemir intracytoplasmicsperminjectioncycleoutcomesinwomenaged40yearsandover AT runaozelci intracytoplasmicsperminjectioncycleoutcomesinwomenaged40yearsandover AT serdardilbaz intracytoplasmicsperminjectioncycleoutcomesinwomenaged40yearsandover AT bernadilbaz intracytoplasmicsperminjectioncycleoutcomesinwomenaged40yearsandover AT emrebaser intracytoplasmicsperminjectioncycleoutcomesinwomenaged40yearsandover AT yaprakustun intracytoplasmicsperminjectioncycleoutcomesinwomenaged40yearsandover |